{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0469-2601",
      "generic_name": "mirabegron",
      "labeler_name": "Astellas Pharma US, Inc.",
      "brand_name": "Myrbetriq",
      "active_ingredients": [
        {
          "name": "MIRABEGRON",
          "strength": "25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0469-2601-07",
          "description": "4 CARTON in 1 TRAY (0469-2601-07)  / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20120628",
          "sample": true
        },
        {
          "package_ndc": "0469-2601-30",
          "description": "1 BOTTLE in 1 CARTON (0469-2601-30)  / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE",
          "marketing_start_date": "20120628",
          "sample": false
        },
        {
          "package_ndc": "0469-2601-90",
          "description": "1 BOTTLE in 1 CARTON (0469-2601-90)  / 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE",
          "marketing_start_date": "20120628",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Astellas Pharma US, Inc."
        ],
        "rxcui": [
          "1300791",
          "1300797",
          "1300801",
          "1300803",
          "2541233",
          "2541237"
        ],
        "spl_set_id": [
          "ba9e9e15-e666-4c56-9271-2e24739cfa2d"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000185008",
          "N0000185007",
          "N0000182137",
          "N0000190114",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "beta3-Adrenergic Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Adrenergic beta3-Agonists [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "unii": [
          "MVR3JL3B2V"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
      "spl_id": "fe8998d8-cf08-4e07-b966-33e8de20abf1",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20120628",
      "product_id": "0469-2601_fe8998d8-cf08-4e07-b966-33e8de20abf1",
      "application_number": "NDA202611",
      "brand_name_base": "Myrbetriq",
      "pharm_class": [
        "Adrenergic beta3-Agonists [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "beta3-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}